$270.000,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

COVID-19 in Alzheimer’s Disease and Dementia crucially summarizes the current status of the coronavirus in patients suffering from these conditions, describing why they are a common cause of morbidity among those with COVID-19. The first section includes chapters that provide a general description of COVID-19, including SARS-CoV-2 structure, function, and biology, and its impact on the elderly with chronic conditions include hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases. Also discussed are effects of the virus on the immune system. The second section shifts to the impact of COVID-19 on those with dementia or Alzheimer’s disease, with special emphasis on age, gender, ethnic background, and lifestyle. Bringing this focus on neurodegenerative disease in one comprehensive resource, this volume is an essential reference for neuroscientists, clinicians, biomedical scientists, and all others working or interested in the field.

  • Discusses Alzheimer’s disease and dementia as morbidities for COVID-19
  • Describes SARS-CoV-2 structure, function, and biology
  • Examines impact on elderly with chronic conditions including hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases
  • Covers the effect of race, gender, and sex as additional risk factors

1. Title of Book - p. i 2. Cover - p. i 3. Title Page - p. i 4. Copyright - p. i 5. List of contributors - p. xi 6. Preface - p. xiv 7. 1 COVID-19 and immunity - p. 4 8. 2 Role of oxidative stress in the severity of SARS-COV-2 infection - p. 34 9. 3 Immune enhancers for COVID-19 - p. 50 10. 4 Diabetes mellitus in relation to COVID-19 - p. 78 11. 5 Food bioactive compounds, sources, and their effectiveness during COVID-19 - p. 93 12. 6 MicroRNAs and COVID-19 - p. 110 13. 7 Mechanisms and implications of COVID-19 transport into neural tissue - p. 124 14. 8 Immunogenetic landscape of COVID-19 infections related neurological complications - p. 134 15. 9 Impact of COVID-19 on ischemic stroke condition - p. 148 16. 10 The psychiatric effects of COVID-19 in the elderly - p. 160 17. 11 Blood brain barrier disruption following COVID-19 infection and neurological manifestations - p. 172 18. 12 The effects of lifestyle in Alzheimer's disease during the COVID-19 pandemic - p. 204 19. 13 Dementia and COVID-19 - p. 216 20. 14 Dementia and COVID-19 - p. 240 21. 15 Women and Alzheimer's disease risk: a focus on gender - p. 260 22. 16 Women and Alzheimer's disease - p. 274 23. 17 Effect of COVID-19 on Alzheimer's and dementia measured through ocular indications - p. 308 24. 18 Surgical and nonsurgical interventions for Alzheimer's disease - p. 316 25. Index - p. 327

Descripcion
Descripción

COVID-19 in Alzheimer’s Disease and Dementia crucially summarizes the current status of the coronavirus in patients suffering from these conditions, describing why they are a common cause of morbidity among those with COVID-19. The first section includes chapters that provide a general description of COVID-19, including SARS-CoV-2 structure, function, and biology, and its impact on the elderly with chronic conditions include hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases. Also discussed are effects of the virus on the immune system. The second section shifts to the impact of COVID-19 on those with dementia or Alzheimer’s disease, with special emphasis on age, gender, ethnic background, and lifestyle. Bringing this focus on neurodegenerative disease in one comprehensive resource, this volume is an essential reference for neuroscientists, clinicians, biomedical scientists, and all others working or interested in the field.

  • Discusses Alzheimer’s disease and dementia as morbidities for COVID-19
  • Describes SARS-CoV-2 structure, function, and biology
  • Examines impact on elderly with chronic conditions including hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases
  • Covers the effect of race, gender, and sex as additional risk factors

1. Title of Book - p. i 2. Cover - p. i 3. Title Page - p. i 4. Copyright - p. i 5. List of contributors - p. xi 6. Preface - p. xiv 7. 1 COVID-19 and immunity - p. 4 8. 2 Role of oxidative stress in the severity of SARS-COV-2 infection - p. 34 9. 3 Immune enhancers for COVID-19 - p. 50 10. 4 Diabetes mellitus in relation to COVID-19 - p. 78 11. 5 Food bioactive compounds, sources, and their effectiveness during COVID-19 - p. 93 12. 6 MicroRNAs and COVID-19 - p. 110 13. 7 Mechanisms and implications of COVID-19 transport into neural tissue - p. 124 14. 8 Immunogenetic landscape of COVID-19 infections related neurological complications - p. 134 15. 9 Impact of COVID-19 on ischemic stroke condition - p. 148 16. 10 The psychiatric effects of COVID-19 in the elderly - p. 160 17. 11 Blood brain barrier disruption following COVID-19 infection and neurological manifestations - p. 172 18. 12 The effects of lifestyle in Alzheimer's disease during the COVID-19 pandemic - p. 204 19. 13 Dementia and COVID-19 - p. 216 20. 14 Dementia and COVID-19 - p. 240 21. 15 Women and Alzheimer's disease risk: a focus on gender - p. 260 22. 16 Women and Alzheimer's disease - p. 274 23. 17 Effect of COVID-19 on Alzheimer's and dementia measured through ocular indications - p. 308 24. 18 Surgical and nonsurgical interventions for Alzheimer's disease - p. 316 25. Index - p. 327

Indice
Autores
Muestra
Ficha Técnica